SCHEMBL18347791

SCHEMBL18347791

COc1c([N+](=O)[O-])cc(OC)c2c1c(C)cc(=O)n2C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 7/20 0.68
▸ NQO2 P16083 6/20 0.68
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ PRKDC P78527 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HTT P42858 2/20 0.38
▸ TDP1 Q9NUW8 3/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18347811 0.77 CYP19A1 (0.75) CYP19A1NQO2ALDH1A1KDM4EMAPT
SCHEMBL21067704 0.71 CYP19A1 (1.00) CYP19A1NQO2ALDH1A1KDM4EMAPT
SCHEMBL9348382 0.69 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTCYP3A4ALOX15
SCHEMBL18347792 0.69 CYP19A1 (0.60) CYP19A1NQO2ALDH1A1KDM4EMAPT
SCHEMBL13000074 0.68 ACHE (0.59) ALDH1A1KDM4EMAPTCYP3A4ALOX15
SCHEMBL14873828 0.68 CYP19A1 (0.77) CYP19A1NQO2ALDH1A1KDM4EMAPT
SCHEMBL11251378 0.67 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTCYP3A4ALOX15
SCHEMBL3294994 0.67 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTCYP3A4ALOX15
SCHEMBL10778338 0.66 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTCYP3A4ALOX15
SCHEMBL210330 0.66 ALDH1A1 (0.68) CYP19A1ALDH1A1KDM4EMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160376243-A1 1,2-NAPHTHOQUINONE BASED DERIVATIVE AND METHOD OF PREPARING THE SAME KT&G LIFE SCIENCES CORPORATION (KR) 2016-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160376243-A1 1,2-NAPHTHOQUINONE BASED DERIVATIVE AND METHOD OF PREPARING THE SAME CYP2S1, SLC5A1, CYP2D6 CYP19A1 138/4885NQO2 144/4885ALDH1A1 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback